Freeline Therapeutics Holdings Plc Adss (FRLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | FRLN | BMY | AMGN | GILD | REGN |
Company | Freeline Therapeutics Holdings Plc Adss | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
Open | 6.49 | 49.89 | 337.03 | 84.39 | 1,149.66 |
High | 6.49 | 50.04 | 338.70 | 84.65 | 1,165.85 |
Low | 6.48 | 49.11 | 334.61 | 83.57 | 1,148.13 |
Last | 6.48 | 49.32 | 336.30 | 84.09 | 1,161.02 |
Change | unch | -0.42 | +3.38 | +0.20 | +22.21 |
% Change | unch | -0.84% | +1.02% | +0.24% | +1.95% |
Volume | 5,600 | 2,070,548 | 429,625 | 2,200,806 | 246,244 |
20-Day Average Volume | 9,370 | 8,266,665 | 1,699,300 | 6,356,512 | 402,381 |
Previous Close | 6.48 | 49.74 | 332.92 | 83.89 | 1,138.81 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 6.43 | 49.10 | 329.63 | 80.08 | 1,166.15 |
20-Day Raw Stochastic | 92.31% | 62.87% | 89.30% | 90.46% | 50.70% |
20-Day Relative Strength | 59.63% | 55.52% | 58.34% | 72.03% | 55.53% |
Weighted Alpha | +4.30 | -10.46 | +27.57 | +18.39 | +43.29 |
Today's Opinion | 100% Buy | 72% Buy | 96% Buy | 88% Buy | 80% Buy |
Previous Opinion | 100% Buy | 72% Buy | 88% Buy | 88% Buy | 80% Buy |
Last Month's Opinion | 88% Buy | 40% Buy | 88% Buy | 56% Buy | 100% Buy |
Performance | |||||
5-Days | |||||
%Chg | +0.78% since 02/09/24 | +2.23% since 09/12/24 | +2.06% since 09/12/24 | +0.99% since 09/12/24 | -0.13% since 09/12/24 |
Low | 6.40 on 02/12/24 | 48.20 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 1,134.59 on 09/17/24 |
High | 6.49 on 02/16/24 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 84.61 on 09/19/24 | 1,170.58 on 09/13/24 |
1-Month | |||||
%Chg | +1.09% since 01/16/24 | +0.03% since 08/19/24 | +2.71% since 08/19/24 | +12.80% since 08/19/24 | -2.84% since 08/19/24 |
Low | 6.36 on 01/24/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 1,113.24 on 09/11/24 |
High | 6.49 on 02/16/24 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
3-Month | |||||
%Chg | +37.58% since 11/16/23 | +20.84% since 06/18/24 | +10.09% since 06/18/24 | +32.98% since 06/18/24 | +11.91% since 06/18/24 |
Low | 4.63 on 11/17/23 | 39.35 on 07/05/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 1,011.67 on 07/03/24 |
High | 6.55 on 12/05/23 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
6-Month | |||||
%Chg | +65.73% since 08/16/23 | -4.80% since 03/19/24 | +23.97% since 03/19/24 | +14.40% since 03/19/24 | +20.68% since 03/19/24 |
Low | 2.60 on 10/06/23 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 875.22 on 04/26/24 |
High | 7.70 on 11/03/23 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
Key Statistics | |||||
Market Capitalization, $K | 28,129 | 100,827,960 | 178,589,936 | 104,514,608 | 125,480,912 |
Shares Outstanding, K | 4,341 | 2,027,100 | 536,435 | 1,245,853 | 110,186 |
Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
Annual Net Income | -88,970,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
Last Quarter Sales | 10,000 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 3,547,100,000 |
Last Quarter Net Income | -12,090,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 | 1,432,300,000 |
60-Month Beta | 0.66 | 0.46 | 0.61 | 0.18 | 0.12 |
Per-Share Information | |||||
Most Recent Earnings | -0.18 on 12/01/23 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 11.56 on 08/01/24 |
Latest Earnings Date | 04/02/24 | 10/31/24 | 10/29/24 | 11/05/24 | 11/07/24 |
Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A |
Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 36.12 | 17.89 | 17.67 | 29.85 |